TRAD UK has more than tripled its original charity fundraising target after overwhelming support from employees and clients helped the company surpass its initial goal in record time.
The scaffolding and access specialist is raising funds for Duchenne UK, a cause close to home for TRAD UK.
Initially aiming to raise £7,000, the company has already brought in more than £20,000 with four months of fundraising left before the campaign concludes in March 2025.
The success has prompted TRAD to raise its target to £30,000, which could significantly aid Duchenne UK’s Grant 4 Scheme. This initiative supports research into gene therapies and treatments for Duchenne Muscular Dystrophy (DMD), a progressive condition that primarily affects boys and is often diagnosed in early childhood.
A Personal Connection
For Danielle and Liam Ackers, whose son Thomas has DMD, the campaign is deeply personal.
“We are absolutely blown away with the support we’ve had from our colleagues and clients at TRAD,” said Danielle Ackers.
“The money we raise will go towards researching innovative treatments that could make a real difference for children like Thomas. Reaching £30,000 would fund vital studies and clinical trials, offering hope for the future.”
The company’s efforts include organised events and ongoing activities across its depots, fostering a culture of generosity and teamwork.
TRAD UK Managing Director Colin Dobson praised the enthusiasm of his team, highlighting the company’s longstanding commitment to charity work. “Raising money for charity is an important part of our culture at TRAD UK,” Dobson said.
“It’s incredible to see how everyone comes together to support these initiatives. We never put pressure on our staff to take part, but their willingness and team spirit are evident across the business. I’m excited to see what we can achieve by the end of the year.”
Skydiving for a Cause
The campaign will culminate in March 2025, with a group of TRAD employees set to take part in a skydiving challenge, further underlining their dedication to the cause.
For the Ackers family, the progress being made in both fundraising and research offers hope.
“Thomas is doing so well, and we are very positive about his future,” said Liam Ackers. “The therapies and approaches that TRAD is helping to fund could be life-changing. We’re incredibly grateful to everyone at TRAD and beyond for their support.”
